Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced (225)Ac

BACKGROUND: Actinium-225 ((225)Ac, t(1/2) = 9.9 d) is a promising candidate radionuclide for use in targeted alpha therapy (TAT), though the currently limited global supply has hindered the development of a suitable Ac-chelating ligand and (225)Ac-radiopharmaceuticals towards the clinic. We at TRIUM...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramogida, Caterina F., Robertson, Andrew K. H., Jermilova, Una, Zhang, Chengcheng, Yang, Hua, Kunz, Peter, Lassen, Jens, Bratanovic, Ivica, Brown, Victoria, Southcott, Lily, Rodríguez-Rodríguez, Cristina, Radchenko, Valery, Bénard, François, Orvig, Chris, Schaffer, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684685/
https://www.ncbi.nlm.nih.gov/pubmed/31659557
http://dx.doi.org/10.1186/s41181-019-0072-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684685/
https://www.ncbi.nlm.nih.gov/pubmed/31659557
http://dx.doi.org/10.1186/s41181-019-0072-5

Ejemplares similares